Roche, Lilly blood test wins FDA clearance for Alzheimer’s aid
RHHBY and LLY say Elecsys pTau217, a biomarker blood test for people aged 55 and older with cognitive decline, received FDA clearance to help identify signs of Alzheimer’s disease.
RHHBY and LLY blood test to help identify signs of Alzheimer's Disease in people aged 55 and older with cognitive decline received FDA clearance.
The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes.